# Post Market Clinical Follow-up of CRT-DX Therapy With Lumax 640/740 HF-T

> **NCT01930695** · — · COMPLETED · sponsor: **Biotronik SE & Co. KG** · enrollment: 18 (actual)

## Conditions studied

- Atrial Fibrillation
- Heart Failure

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01930695
- **Lead sponsor:** Biotronik SE & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01930695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01930695, "Post Market Clinical Follow-up of CRT-DX Therapy With Lumax 640/740 HF-T". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01930695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*